El próximo viernes 12 de abril, a las 12:30 h en el aula B5, contaremos con la participación del Dr. Alejandro Rojas-Fernández (Founder and CEO, Berking Biotechnology & Theranostics. Prof. Universidad Austral de Chile) que impartirá la conferencia titulada Nuevas tecnologías biomédicas a partir del sistema inmune de alpacas. Esta conferencia ha sido organizada por el profesor José Lozano del Dpto. de Biología Molecular y Bioquímica.
Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology. Aguado et al. Nat Aging. 2023 Dec;3(12):1561-1575. doi: 10.1038/s43587-023-00519-6.
SUMO protease SENP6 protects the nucleus from hyperSUMOylation-induced laminopathy-like alterations. Liczmanska et al. Cell Rep. 2023 Aug 29;42(8):112960. doi: 10.1016/j.celrep.2023.112960.
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants. Modhiran et al. iScience. 2023 Jun 9;26(7):107085. doi: 10.1016/j.isci.2023.107085
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody. Valenzuela et al. Sci Rep. 2021 Feb 8;11(1):3318. doi: 10.1038/s41598-021-82833-w.
Rapid generation of endogenously driven transcriptional reporters in cells through CRISPR/Cas9. Rojas-Fernandez A et al. Sci Rep. 2015 Apr 29;5:9811. doi: 10.1038/srep09811.
SUMO chain-induced dimerization activates RNF4. Rojas-Fernandez A et al. Mol Cell. 2014 Mar 20;53(6):880-92. doi: 10.1016/j.molcel.2014.02.031.
